Cochrane Abstracts
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants. Accessed March 24, 2025.
Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants
Continuous Infusion Versus Intermittent Bolus Doses of Indomethacin for Patent Ductus Arteriosus Closure in Symptomatic Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Continuous infusion versus intermittent bolus doses of indomethacin for patent ductus arteriosus closure in symptomatic preterm infants
ID - 436862
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436862/all/Continuous_infusion_versus_intermittent_bolus_doses_of_indomethacin_for_patent_ductus_arteriosus_closure_in_symptomatic_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
